CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Licker, M.
Right arrow Articles by Morel, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Licker, M.
Right arrow Articles by Morel, D. R.

Canadian Journal of Anesthesia, Vol 46, 626-634, Copyright © 1999 by Canadian Anesthesiologists' Society

ARTICLES

Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery

M Licker, A Schweizer, L Hohn and DR Morel
Division of Anesthesiology, Hopital Cantonal Universitaire, Geneve, Switzerland. marc-joseph.licker@hcuge.ch

PURPOSE: Treatment with angiotensin-converting enzyme (ACE) inhibitors affects the autoregulation of renal blood flow and glomerular filtration and provides renal protective effects. The purpose of this case-control study was to investigate the effects of chronic ACE inhibition on perioperative renal hemodynamics and function. METHOD: We prospectively studied renal function in two groups of patients, chronically treated or not, with ACE inhibitors (ACEI and control; n = 16, in each group) who underwent elective cardiac surgery under hypothermic cardiopulmonary bypass. Glomerular filtration rate, effective renal plasma flow, osmolar clearance and fractional excretion of sodium and potassium were determined before, during and after CPB. Additional measurements included plasma atrial natriuretic factor (ANF) as well as plasma and urinary cyclic GMP (cGMP), thromboxane B2 (TxB2) and 6-keto-PGF1. RESULTS: Renal functional and hemodynamic variables did not differ between the two groups, at any period. Cardiopulmonary bypass induced increases in urinary flow, osmolar clearance and fractional excretion of sodium and potassium in both groups. Plasma and urinary ratio of 6-keto-PGF to TxB2 increased markedly and reflected a predominant systemic and renal release of vasodilatory prostaglandins. Intraoperatively, ANF was higher in ACEIs than in control patients. CONCLUSIONS: Long term treatment with ACE inhibitors does not influence the perioperative changes in renal hemodynamics and function. During cardiopulmonary bypass, a transient impairment in solute reabsorption is associated with renal release of vasodilatory mediators (nitric oxide and prostacyclin).


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M.-L. Cittanova, A. Zubicki, C. Savu, C. Montalvan, N. Nefaa, K. Zaier, B. Riou, and P. Coriat
The Chronic Inhibition of Angiotensin-Converting Enzyme Impairs Postoperative Renal Function
Anesth. Analg., November 1, 2001; 93(5): 1111 - 1115.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. C. Schoolwerth, D. A. Sica, B. J. Ballermann, and C. S. Wilcox
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy: A Statement for Healthcare Professionals From the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association
Circulation, October 16, 2001; 104(16): 1985 - 1991.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Canadian Anesthesiologists' Society.